share_log

PureTech Health Cuts Karuna Therapeutics Stake to 20.4%

PureTech Health Cuts Karuna Therapeutics Stake to 20.4%

百昱健康將卡魯娜治療學的股份削減至 20.4%
道琼斯 ·  2020/01/23 17:12

DJ PureTech Health Cuts Karuna Therapeutics Stake to 20.4%

DJ 百昱健康科技將卡魯娜治療學的股份削減至 20.4%



By Adria Calatayud

由亞德里亞卡拉塔尤德



PureTech Health PLC (PRTC.LN) said Thursday that it has cut its stake in Boston-based Karuna Therapeutics Inc. (KRTX) to 20.4%, raising $200 million in cash.

PURTech 健康有限公司(PRTC.LN)週四表示,它已將其在波士頓的卡魯納治療公司(KRTX)的股份削減至 20.4%,籌集了 2 億美元的現金。

PureTech, a Boston-based, London-listed biotechnology company, said it sold 2.1 million Karuna shares to Goldman Sachs Group Inc. (GS), after which it continues to hold 5.3 million shares in the Nasdaq-listed company. PureTech continues to have a right to royalty payments on net sales of any commercialized product covered by a license granted to Karuna, it said.

總部位於波士頓的倫敦上市生物技術公司 PureTech 表示,該公司向高盛集團(GS)出售 210 萬股 Karuna 股份,之後繼續持有納斯達克上市公司 530 萬股股份。它說,PureTech 繼續有權在授予 Karuna 的許可證涵蓋的任何商業化產品的淨銷售額上支付版稅。

PureTech said the sale provides it with additional cash to fund its growth.

PureTech 表示,該次出售為其提供了額外的現金來為其增長提供資金。

PureTech shares at 0906 GMT were down 1% at 290 pence.

在 0906 格林威治標準時間的純科技股份下跌 1%,達 290 便士。



Write to Adria Calatayud at adria.calatayud@dowjones.com

寫信給亞德里亞卡拉塔尤德 adria.calatayud@dowjones.com



(END) Dow Jones Newswires

(完) 道瓊斯通訊社

January 23, 2020 04:12 ET (09:12 GMT)

2020 年一月 23 日 04:12 東部時間 (格林威治標準時間 09:12)

Copyright (c) 2020 Dow Jones & Company, Inc.

版權所有 (c) 2020 道瓊斯公司

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論